Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v8-EN
Language French English
Date Updated 2020-03-26 2020-03-26
Drug Identification Number 02311658 02311658
Brand name ATACAND ATACAND
Common or Proper name candesartan cilexetil candesartan cilexetil
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH CHEPLAPHARM ARZNEIMITTEL GMBH
Ingredients CANDESARTAN CILEXETIL CANDESARTAN CILEXETIL
Strength(s) 32MG 32MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 tablets 30 tablets
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-02-12 2020-02-12
Actual start date 2020-02-12 2020-02-12
Estimated end date 2020-03-27 2020-03-27
Actual end date 2020-03-25 2020-03-25
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments